期刊文献+

达英-35治疗青春期多囊卵巢综合征患者并发功血的临床疗效观察 被引量:5

下载PDF
导出
摘要 目的探讨达英-35治疗青春期多囊卵巢综合征患者并发功血止血、调整周期,改善高雄激素体征的近期疗效。方法对35例诊断为青春期多囊卵巢综合征并发功血的临床资料进行回顾性分析。其中口服达英-35,均为3片/d,血止后2片/d×3d,之后1片/d×21d。通过分析患者急性出血减少时间、出血停止时间以及比较患者治疗前后月经情况、血红蛋白的数值、体重指数、生殖内分泌激素等指标,对达英-35治疗青春期多囊卵巢综合征并发功血进行疗效评价。结果 35例均在72h内止血,平均为(22.23±15.38)h;服用达英-35治疗3周期、6周期后月经量PBAC评分较治疗前明显下降,3周期后血红蛋白由治疗前的(92.31±23.07)g/L上升至(103.71±13.06)g/L;6周期后33例患者血红蛋白恢复正常,平均为(116.60±5.62)g/L,差异有统计学意义;治疗6周期后体重指数平均值为23.54kg/m2,较治疗前无明显增加;服用达英-35 3周期、6周期后生殖内分泌激素(LH、FSH、E2、T)与治疗前比较均呈下降趋势,差异有统计学意义;副反应轻微。结论用达英-35治疗青春期多囊卵巢综合征并发功血在迅速止血、控制周期和改善高雄激素体征等方面近期疗效尚佳。
出处 《中国现代医生》 2011年第15期57-58,共2页 China Modern Doctor
  • 相关文献

参考文献6

  • 1The Rotterdam ESHRE/ASRM2Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome ( PCOS )[J]. Hum Rep Rod,2004,19( 1 ): 41-47.
  • 2李荣环,杨欣.短效口服避孕药治疗青春期急性重症功血的临床疗效观察[J].山西医科大学学报,2009,40(11):1041-1043. 被引量:11
  • 3Higham JM,O' Brien PM, Shaw BW. Assessment of menstrual blood loss using a pictorial chart [J]. BrJ Obstet Gynecol, 1990, 97 ( 8 ) : 734-739.
  • 4李央,林金芳,朱铭伟,孙莉.多囊卵巢综合征患者并发子宫内膜增生症的临床研究[J].现代妇产科进展,2009,18(9):687-690. 被引量:4
  • 5李家泰.临床药物学[M].第2版.北京:人民卫生出版社,2007:1690-1697.
  • 6North American Society for Pediatric and Adolescent Gynecology.Dysfunction uterine bleeding in adolescents[J]. J Pediatr Adolesc Gynecol, 2006, 19 ( 1 ): 49-51.

二级参考文献20

  • 1刘颖,徐苓.雌激素或避孕药治疗青春期功能性子宫出血的效果分析[J].生殖医学杂志,2006,15(3):145-149. 被引量:21
  • 2孙爱军.功能失调性子宫出血的性激素治疗[J].中国实用妇科与产科杂志,2006,22(9):650-652. 被引量:84
  • 3Elliott JL, Hosford SL, Demopoulos RL, et al. Endometrial adenocarcinoma and polycystic ovary syndrome:risk factors, management, and prognosis [ J ]. South Med, 2001, 94:529-531.
  • 4The Rotterdam ESHRE/ASRM-Sponsored PCOS consen sus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [ J]. Hum Reprod ,2004,19:41 - 47.
  • 5World Health Organization, Kurman RJ. Blaustein's Pathology of the Female Genital Tract [ M ]. 5th ed. New Youk : Spring-Verlag, 2002 : 467-500.
  • 6Tingthanatikul Y, Choktanasiri W, Rochanawutanon M, et al. Prevalence and clinical predictors of endometrial hyperplasia in anovulatory women presenting with amenorrhea[ J]. Gynecol Endocrinol,2006,22 : 101-105.
  • 7Cheung AP. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome [ J]. Obstet Gynecol,2001,98 :325-331.
  • 8Reed SD, Newton KM, Clinton WL, et al. Incidence of endometrial hyperplasia [ J ] Am J Obstet Gynecol, 2009, 200:678. e1 -678. e6.
  • 9Farquhar CM, Lethaby A, Sowter M, et al. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding [ J ]. Am J Obstet Gynecol, 1999,181 : 525-529.
  • 10Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with post menopausal bleeding--a Nordic muhicenter study[ J]. Am J Obstet Gynecol, 1995,172 : 1488-1494.

共引文献13

同被引文献34

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部